IP Library Granted Patent US 9,580,478
Granted Patent B2
US 9,580,478 · App. 13/795,445 · Granted Feb 28, 2017

Vaccines comprising heat-sensitive transgenes

Inventor: Francis E. Nano (Victoria, CA)
Assignee: UVIC INDUSTRY PARTNERSHIPS INC.
C07K14/195A61K35/74C12N9/00C12N9/1014C12N9/88C12N9/93C12N15/74A61K2039/521A61K2039/523
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,478
App. No.
13/795,445
Granted
Feb 28, 2017
Kind
B2
Abstract

The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid molecules, as well as recombinant cells into which have been introduced such nucleic acid molecules. The disclosed recombinant cells containing one or more essential nucleic acid molecules from a psychrophilic bacterium are thereby made temperature sensitive, and can be administered to a mammal to induce an immune response in the mammal.

Claims (38)

1. A method of making a recombinant mesophilic bacterium that is temperature-sensitive (TS), comprising:

introducing into the genome of a mesophilic bacterium by homologous recombination a nucleic acid construct comprising a TS essential nucleic acid molecule from a psychrophilic bacterium flanked on both sides by a nucleic acid molecule homologous to a region of the mesophilic bacterium genome where the TS essential nucleic acid molecule from the psychrophilic bacterium will be inserted into the mesophilic bacterium genome, and

functionally replacing the mesophilic bacterium's homolog of the TS essential nucleic acid molecule, thereby making a recombinant mesophilic bacterium that is TS,

wherein a protein encoded by the TS essential nucleic acid molecule is operable at a temperature less than 30° C. and inoperable at a temperature greater than 30° C., and

wherein the recombinant mesophilic bacterium that is TS has a restrictive temperature between 33° C. and 44° C.

2. A method of making a killed recombinant mesophilic bacterium that is temperature-sensitive (TS), comprising:

introducing into the genome of a mesophilic bacterium a nucleic acid construct comprising a TS essential nucleic acid molecule from a psychrophilic bacterium flanked on both sides by a nucleic acid molecule homologous to a region of the mesophilic bacterium genome where the TS essential nucleic acid molecule from the psychrophilic bacterium will be inserted into the mesophilic bacterium genome,

wherein a protein encoded by the TS essential nucleic acid molecule is operable at a temperature less than 30° C. and inoperable at a temperature greater than 30° C., and

wherein the recombinant mesophilic bacterium that is TS is viable at a temperature of 0° C. to 30° C., nonviable at a temperature greater than 30° C., and has a restrictive temperature between 33° C. and 44° C.;

culturing the recombinant mesophilic bacterium that is TS at a temperature wherein a protein encoded by the TS essential nucleic acid molecule is operable, whereby the recombinant mesophilic bacterium that is TS produces a plurality of peptides;

increasing the culturing temperature to a temperature at which a protein encoded by the TS nucleic acid molecule is inoperable;

maintaining said culturing for a period of time sufficient to kill the recombinant mesophilic bacterium that is TS; and

harvesting the killed recombinant mesophilic bacterium that is TS.

3. A method of making a recombinant mesophilic bacterium that is temperature-sensitive (TS), comprising:

introducing into the genome of a mesophilic bacterium a nucleic acid construct comprising a TS essential nucleic acid molecule from a psychrophilic bacterium, and

functionally replacing the mesophilic bacterium's homolog of the TS essential nucleic acid molecule, thereby making a recombinant mesophilic bacterium that is TS,

wherein a protein encoded by the TS essential nucleic acid molecule is operable at a temperature less than 30° C. and inoperable at a temperature greater than 30° C., and

wherein the recombinant mesophilic bacterium that is TS has a restrictive temperature between 33° C. and 44° C.

4. The method of claim 3 , wherein the psychrophilic bacterium is Colwellia sp., Pseudoalteromonas sp., or Shewanella sp.

5. The method of claim 3 , wherein the protein encoded by the TS essential nucleic acid molecule comprises the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, or 28.

6. The method of claim 3 , wherein one or more control sequences are operably linked to the TS essential nucleic acid molecule.

7. The method of claim 3 , wherein introducing into the genome of the mesophilic bacterium the nucleic acid construct comprising a TS essential nucleic acid molecule from the psychrophilic bacterium comprises introducing into the genome of the mesophilic bacterium by homologous recombination one or more TS essential nucleic acid molecules from the psychrophilic bacterium.

8. A recombinant mesophilic bacterium that is temperature-sensitive (TS) made by the method of claim 3 .

9. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the recombinant mesophilic bacterium that is TS is a Francisella novicida cell.

10. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the recombinant mesophilic bacterium that is TS is a fermentative microbial strain or a bioremediation strain.

11. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the psychrophilic bacterium is Colwellia sp., Pseudoalteromonas sp., or Shewanella sp.

12. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the psychrophilic bacterium is Pseudoalteromonas haloplanktis or C. psychrerhraea.

13. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the mesophilic bacterium that is TS is Haemophilus sp., Vibrio sp., Escherichia sp., Streptococcus sp., Burkholderia sp., Campylobacter sp., Neisseria sp., Francisella sp., Salmonella sp. or Mycobacterium sp.

14. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the TS essential nucleic acid molecule comprises the nucleotide sequence shown in SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 or 27, wherein expression of the TS essential nucleic acid molecule confers temperature sensitivity.

15. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the protein encoded by the TS essential nucleic acid molecule comprises the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, or 28.

16. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the protein encoded by the TS essential nucleic acid molecule is operable at a temperature above of 4° C. and inoperable at a temperature greater than 30° C.

17. The recombinant mesophilic bacterium that is TS of claim 8 , wherein the nucleic acid construct comprising the TS essential nucleic acid molecule comprises a vector.

18. A composition comprising the recombinant mesophilic bacterium that is TS of claim 8 .

19. The composition of claim 18 , wherein the composition is an immunogenic or therapeutic composition.

20. The composition of claim 18 , further comprising an adjuvant.

21. The composition of claim 18 , further comprising a pharmaceutically acceptable carrier.

22. The composition of claim 18 , comprising more than one type of recombinant mesophilic bacterium that is TS.

23. The composition of claim 18 , wherein the recombinant mesophilic bacterium that is TS is a Francisella sp., Salmonella sp., or Mycobacterium sp.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2013
From: NANO, FRANCIS E.
To: UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION
Reel/Frame 029972/0205 →
CHANGE OF NAME Recorded Mar 12, 2013
From: UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION
To: UVIC INDUSTRY PARTNERSHIPS INC.
Reel/Frame 029972/0211 →
Continuity (4)
Continuation 13496723
Provisional Application 61249385 · Oct 7, 2009
Provisional Application 61322634 · Apr 9, 2010
Related Publication 20130177589A1 · Jul 11, 2013